A detailed history of American Portfolios Advisors transactions in Nkarta, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 4,325 shares of NKTX stock, worth $10,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,325
Holding current value
$10,769
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$12.27 - $18.39 $53,067 - $79,536
4,325 New
4,325 $56.9 Million
Q2 2022

Mar 20, 2023

SELL
$7.77 - $19.44 $1,942 - $4,860
-250 Reduced 5.78%
4,075 $50.2 Million
Q1 2022

Mar 21, 2023

SELL
$8.66 - $14.99 $4,546 - $7,869
-525 Reduced 12.14%
3,800 $43.2 Million
Q4 2021

Mar 21, 2023

SELL
$12.79 - $26.88 $25,260 - $53,088
-1,975 Reduced 45.66%
2,350 $36.1 Million
Q3 2021

Mar 22, 2023

SELL
$26.67 - $38.76 $102,679 - $149,226
-3,850 Reduced 89.02%
475 $13.2 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $121M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.